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ABSTRACT 
Background: The Pediatric Heart Network Collaborative Learning Study (PHN CLS) increased 
early extubation rates after infant Tetralogy of Fallot (TOF) and coarctation (CoA) repair across 
participating sites by implementing a clinical practice guideline (CPG).  The impact of the CPG 
on hospital costs has not been studied.  
Methods: PHN CLS clinical data were linked to cost data from Children’s Hospital Association 
by matching on indirect identifiers.  Hospital costs were evaluated across active and control 
sites in the pre- and post-CPG periods using generalized linear mixed effects models.  A 
difference-in-difference approach was used to assess whether changes in cost observed in 
active sites were beyond secular trends in control sites.  
Results: Data were successfully linked on 410/428 (96%) of eligible patients from 4 active and 
4 control sites.  Mean adjusted cost/case for TOF repair was significantly reduced in the post-
CPG period at active sites ($42,833 vs. $56,304, p<0.01) and unchanged at control sites 
($47,007 vs. $46,476, p=0.91), with an overall cost reduction of 27% in active vs. control sites 
(p=0.03). Specific categories of cost reduced in the TOF cohort included clinical (-66%, p<0.01), 
pharmacy (-46%, p=0.04), lab (-44%, p<0.01), and imaging (-32%, p<0.01). There was no 
change in costs for CoA repair at active or control sites.   
Conclusions: The early extubation CPG was associated with a reduction in hospital costs for 
infants undergoing repair of TOF, but not CoA repair. This CPG represents an opportunity to 
both optimize clinical outcome and reduce costs for certain infant cardiac surgeries. 
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In the current healthcare environment, there is increasing emphasis on both improving quality of 
care and reducing costs, or providing high “value” care. Congenital heart disease accounts for 
the highest hospital costs among all children with birth defects, and is among the most frequent 
high-cost conditions treated at children’s hospitals across all pediatric diseases1,2.   
 
Few studies have evaluated specific interventions that may hold the potential to both improve 
clinical outcomes and lower costs in this population. The Pediatric Heart Network Collaborative 
Learning Study (PHN CLS)3 demonstrated that a collaborative learning strategy involving 
development and implementation of a clinical practice guideline (CPG) was successful in 
significantly increasing the rate of early extubation (extubation within 6 hours of admission to the 
intensive care unit) in infants undergoing repair of Tetralogy of Fallot (TOF) and coarctation of 
the aorta (CoA) at active sites compared to controls.  At active sites, the rate of early extubation 
increased from 11.7% to 66.9% (p<0.001).  Other key findings included a significant decline in 
postoperative critical care length of stay (LOS) in the TOF group (44.2 vs. 51.8 hours, p=0.04), 
although there was no change in total hospital LOS in either the TOF or CoA patients. In 
addition, time to discontinuation of continuous intravenous analgesics and time to introduction of 
oral feeds were reduced following introduction of the CPG with more prominent changes in the 
TOF group. It is not known whether these changes translated into reductions in hospital costs, 
as there may be other practices and factors influencing cost of care for these patients across 
hospitals beyond the timing of extubation and associated factors4,5.  
 
This study merges PHN CLS clinical data with cost data from the Children’s Hospital 
Association Inpatient Essentials database to study the impact of the CPG on hospital costs. In 
addition to an assessment of total hospital costs in the pre- and post-CPG periods, we also 
evaluated specific cost categories in order to assess which of these may be the most impacted.    
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PATIENTS AND METHODS 
Data Sources  
The PHN CLS was performed over a two-year period from 2013 to 2015.  The methods and 
main study results have been previously published3,6.   Briefly, the investigative team observed 
clinically important variation in postoperative mechanical ventilation practices and clinical 
outcomes after infant surgery at five congenital heart programs6.  One hospital was identified as 
a positive outlier with much lower median ventilation times and shorter length of stay.  
Participants engaged in a series of round-robin site visits and then created a CPG to mimic the 
extubation strategy and associated key practices at the “model” hospital after infant repair of 
TOF and CoA.  In the main study, clinical outcomes at the four active hospitals who 
implemented the CPG were measured during the 12 months before (pre-CPG) and the 12 
months after (post-CPG) implementation, and were compared with 5 other PHN sites during the 
same time period (controls) who continued with usual practice3. 
 
 
The Inpatient Essentials database (formally known as the Case Mix database) is a large 
administrative database maintained by Children’s Hospital Association (CHA; Lenexa, KS). The 
database contains total hospital resource utilization and other inpatient data from 90 US 
children’s hospitals7.  
 
Linkage 
PHN CLS clinical data and hospital cost data from the Inpatient Essentials database were linked 
at the patient level using the method of probabilistic matching of indirect identifiers as previously 
described7,8. The following identifiers were utilized for record linkage: center, gender, date of 
admission (+/- 1 day), date of discharge (+/- 1 day), and date of birth (+/- 1 day).    
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The analysis performed for this project was a pre-specified secondary aim of the primary PHN 
CLS, which was reviewed and approved by the PHN’s Data and Safety Monitoring Board as 
well the individual centers’ Institutional Review Boards (IRB) with waiver of informed consent.   
 
Study Population 
All patients enrolled in the PHN CLS were eligible for inclusion3.  Similar to the main analysis, 
the “model center” was excluded as it served as the prototype for CPG development. 
Additionally, one non-US center was excluded from the control sites as it did not contribute data 
to the CHA Inpatient Essentials Database. 
 
Data Collection 
Data collected as a part of the PHN CLS have been previously reported3. All clinical data for this 
study was obtained from variables in the PHN CLS. Data contained in CHA Inpatient Essentials 
Database were used to estimate hospital costs as described below. These data consist of daily 
total hospital charges, hospital and department specific cost-to-charge ratios, and daily line item 
charges for every service grouped into standard categories including:  clinical, pharmacy, 
imaging, laboratory, supplies, and “other”. Of note, the “other” category is primarily comprised of 
room and board costs, and the clinical service category includes costs related to testing, 
procedures, and other aspects of clinical care delivery such as mechanical ventilation and other 
respiratory care. Professional fees are not captured by CHA or other frequently used 
administrative datasets and therefore could not be included in the analysis.  CHA does not 
separate out facility fees from other charges. 
 
Analysis 
Total hospital costs were estimated from charges using hospital and year specific cost-to-
charge ratios for the time periods before and after CPG implementation with a three-month 
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wash-out phase for each period. Hospital costs were adjusted for geographic region using the 
Centers for Medicare and Medicaid Services price wage index, and values were indexed to 
2015 US dollars to account for inflation. 
 
Total hospital costs were modeled as continuous variables in mixed effects models. Separate 
models were constructed for the TOF and CoA patients.  The skewed distribution of cost was 
accounted for by using a gamma distribution and a random intercept was used for each hospital 
to account for patient clustering within center. Models were adjusted for any clinical variables 
which approached significance in bivariate analyses (p<0.2), which included diagnosis type for 
the CoA cohort (see Table 1).  
 
These models were utilized in a difference-in-difference (DID) analysis.  This approach, which 
employs econometric techniques, isolates changes in outcomes associated with an event of 
interest above and beyond any changes in a control group not exposed to the event or change9-
11
.  This methodology allowed us to evaluate the impact of the CPG on hospital costs at active 
sites, taking into account cost trends during the study period at the control sites.  This approach 
has been employed across several fields to examine a number of outcomes before and after the 
implementation of various policies or initiatives9,12,13.   
  
Finally, in addition to total hospital costs, categories of cost described in the preceding sections 
were also assessed, followed by specific line items for which we anticipated there might be 
reductions given the clinical context and findings of the main CLS study. All analyses were 
performed using SAS version 9.4 (SAS Institute Incorporated, Cary, North Carolina). A p-value 
<0.05 was considered statistically significant. 
 
RESULTS 
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Study Population 
All 4 active PHN CLS sites and 4 control sites were included. As described in the preceding 
section, one model site and one non-US control site was excluded. From these sites, data were 
successfully linked between the CLS PHN and CHA datasets on 410/428 (96%) eligible 
patients. The remaining 23 unmatched patients were distributed among 6 sites, with a range of 
0-5 unmatched patients per site.   
 
Study population characteristics are displayed in Table 1. Median age at surgery was 20 days 
for CoA patients and 153 days for TOF.  On average, CoA patients underwent surgery on 
hospital day 4 with 74.3% of hospital costs occurring on or after the day of surgery.  TOF 
patients underwent surgery on average on hospital day 2 with 85.9% of hospital costs occurring 
on or after the day of surgery. 
 
TOF Costs Pre- and Post-CPG 
The mean adjusted cost per case in the TOF cohort across the pre- and post-CPG periods are 
shown in Table 2.  There was no significant difference in the pre-CPG hospital costs in the 
active versus control sites (p=0.35).  Assessing change over time at the active sites, there was 
a significant reduction in mean adjusted cost per case following CPG implementation ($56,304 
in pre-CPG period vs. $42,833 in post-CPG period, p<0.001).  At the control sites, there was no 
significant change from the pre- to post-CPG periods (Table 2). Overall, our difference-in-
difference analysis showed that there was a 27% reduction in hospital costs in the active vs. 
control sites (95% CI -42% to -13%, p=0.03) in the TOF cohort.  
 
Specific categories of cost are displayed in Figure 1.   We found the greatest reduction in 
hospital costs from the pre- to post-CPG period for the “clinical” category (-66%, p<0.01). 
Notably for the purpose of this study, the clinical category also includes costs related to 
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mechanical ventilation and other respiratory care.  Significant reductions were also seen for 
pharmacy (-46%, p=0.04), laboratory (-44%, p<0.01), and imaging (-32%, p<0.01) costs.  There 
was no significant change in supplies or other costs; of note the “other” category is primarily 
comprised of room and board costs.  
 
In addition to these overall categories, we further examined specific line items of interest. Within 
the clinical category, we found significant reductions in costs related to mechanical ventilation (-
161%, p=0.03) and nebulized mist treatments (-110%, p=0.04). In the pharmacy domain, there 
were significant reductions for ketamine (-139%, p=0.005) and fentanyl (-125%, p<0.001). In the 
lab category, blood gas costs were reduced (-39%, p=0.01), and there was a trend toward 
reduction of chest x-ray costs within the imaging domain (-22%, p=0.07).  
 
CoA Costs Pre- and Post-CPG 
The mean adjusted costs per case in the CoA cohort across the pre- and post-CPG periods are  
shown in Table 2. There was no significant change in costs over time from the pre- to post-CPG 
periods in either the active or control sites for CoA repair.  
 
COMMENT 
In this study, we merged PHN CLS clinical data with cost data from a large CHA dataset to 
study the impact of an early extubation CPG on hospital costs after infant cardiac surgery. We 
found a significant reduction in hospital costs associated with the CPG for infants undergoing 
TOF repair, while there was no change in hospital costs for those undergoing CoA repair.  
 
Although both cohorts in the study had increased rates of early extubation following CPG 
implementation in the primary study, the cost reduction we found in the present analysis was 
limited to the TOF group. These observations mirror those from the primary study3 where 
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improvements in some of the secondary endpoints examined were more prominent in the TOF 
group than the CoA group. These included reduced intensive care unit length of stay in the TOF 
group but not the CoA group, a more prominent decrease in time to discontinuation of all 
continuous sedation/analgesia in the TOF compared to CoA group, and significant declines in 
cumulative doses of specific sedation/analgesia medications in TOF patients compared to no 
change in CoA patients3.  
 
These findings were further highlighted by our examination of specific cost categories and line 
items that were reduced in the TOF cohort.  With earlier extubation, clinical costs, specifically 
those related to mechanical ventilation and respiratory care, were reduced.  Consistent with the 
primary study findings regarding analgesia and sedation3, pharmacy costs and related specific 
line items were also reduced. Despite the reduced intensive care unit length of stay3, room and 
board costs (which comprised the majority of the “other” category) were not significantly 
reduced. This may be because the main CLS study demonstrated no change in total hospital 
LOS. Laboratory and imaging costs were lower, which could be related to the de-escalation of 
care that is typically associated with transition from the intensive care unit and/or associated 
with the shorter duration of mechanical ventilation, as declines in costs related to blood gasses 
and chest x-rays were seen.  
 
Within the CoA group, we hypothesized that the hospital costs associated with non-cardiac care 
of newborns with critical CoA may mask changes from a CPG focused on post-operative care, 
while in contrast most TOF patients are older infants likely admitted from home within 24 hours 
of surgery to undergo elective repair. We found that CoA patients did indeed have a longer pre-
operative hospital stay in our analysis, with a lower proportion of overall hospital costs related to 
the post-operative period compared to the TOF group. 
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The potential implications for cost savings related to implementation of this CPG are 
considerable. For example, recent data from the Society of Thoracic Surgeons Congenital Heart 
Surgery Database suggest approximately 1,250 TOF repairs occur annually in the United 
States14. Based on the cost estimates for TOF repair in our study and the magnitude of 
reduction associated with the CPG, this could translate into total cost savings of ~ $10-15 
million each year for repair of TOF alone.  
 
Through employing data linkage techniques, our study was able to provide unique insights that 
supplement the primary PHN CLS findings. Specifically, by merging clinical PHN CLS data with 
administrative data from CHA through linking on indirect identifiers, we were able to understand 
the impact of the quality improvement initiative not only on clinical outcomes, but costs of care 
as well.  Similar techniques have been used to merge cost data with trial datasets and registry 
data8,15-18 and highlight how this methodology can foster investigations not otherwise possible 
with isolated datasets alone. The methods used in the present analysis can be applied to other 
quality initiatives to support more comprehensive understanding of healthcare value, and the 
impact of various initiatives geared toward optimizing both clinical outcomes and costs of care.  
 
Limitations 
There are several limitations to consider. Our results relate to the two forms of infant heart 
surgery examined as a part of the PHN CLS (TOF and CoA repair, both resulting in biventricular 
circulations and normal oxygen saturations), and may not be generalizable to all forms of 
congenital heart disease or outside of the context of the 8 centers included in this analysis. 
Regarding the changes in hospital costs observed in our study, it is possible that these could be 
related to other general improvements in care over time rather than the early extubation CPG. 
However, the inclusion of control sites and use of a difference-in-difference design to account 
for secular trends makes this unlikely. The observation of cost reductions in the categories that 
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we would expect to be most impacted by the CPG based on the clinical findings also supports 
the validity of our findings. It is possible that our analysis was underpowered to detect small 
changes in hospital costs over time.  In addition, although standard methods were employed 
across hospitals to derive estimated hospital costs, it is possible that some cost differences 
were related more to hospital accounting practices and/or regional differences rather than actual 
resources utilized.  However, the design of this study, in which a center’s data from the post-
CPG era were compared to their data from the pre-CPG period, mitigates some of these 
concerns related to center effects.  Finally, given the findings of the accompanying study in this 
issue of the Annals by Gaies et al.19 regarding limited sustainability of the early extubation CPG 
practices and outcomes at most centers, it is possible that some of the gains described here 
may not persist over time. Further efforts are necessary to investigate strategies to support 
sustainability, whether related to clinical outcomes or hospital costs. 
 
Conclusions 
This study demonstrates that implementation of an early extubation CPG through a 
collaborative learning approach was associated with reduced hospital costs for certain infant 
cardiac surgeries, in addition to the improvement in certain clinical outcomes observed during 
the study period. With the ability to both reduce hospital costs and improve outcomes, the early 
extubation CPG has potential to improve value in infant heart surgery. These results and the 
unique methodology employed in this study can inform future initiatives aimed at improving 
healthcare value across other patient populations. Further investigation into strategies to 
promote sustainability is also necessary. 
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TABLE 1: Study Population Characteristics 
 
 
 CoA TOF 
  
Total 
N=163 
Active 
N=85 
Controls 
N=78 p 
Total 
N=247 
Active 
N=141 
Controls 
N=106 p 
Male  103 (63%) 
53 
(62%) 
50 
(64%) 0.82 
141 
(57%) 
78 
(55%) 
63 
(59%) 0.52 
Birth weight (kg) 3.3 [2.8-3.6] 
3.3 
[2.8-3.6] 
3.2 
[2.9-3.6] 0.84 
3.1 
[2.7-3.4] 
3.1 
[2.8-3.5] 
3.1 
[2.8-3.5] 0.56 
Gestational age <37wks 16 (10.7%) 
8 
(10.3%) 
8 
(11.1%) 0.87 
33 
(15.9%) 
20 
(16.1%) 
13 
(15.5%) 0.90 
Age at surgery (days) 20 [7-59] 
19 
[7-63] 
20.5 
[8-52] 0.99 
153 
[112-208] 
153 
[125-198] 
152 
[92-219] 0.49 
Chromosomal anomaly 1 (0.6%) 
1 
(1.2%) 0 0.34 
8 
(3.2%) 
6 
(4.3%) 
2 
(1.9%) 0.30 
Diagnosis  
     Isolated Coarctation 64 (39.3%) 
35 
(41.2%) 
29 
(37.2%) 
0.18 NA 
     Isolated Coarctation       
     + VSD (not requiring  
      intervention) 
21 
(12.9%) 
7 
(8.2%) 
14 
(17.9%) 
     Coarctation + other     
     lesion 
78 
(47.9%) 
43 
(50.6%) 
35 
(44.9%) 
     TOF + PS 
NA 
236 
(95.5%) 
135 
(95.7%) 
101 
(95.3%) 
0.98 
     TOF + AVSD 9 (3.6%) 
5 
(3.5%) 
4 
(3.8%) 
     TOF + Absent 
     pulmonary valve 
2 
(0.8%) 
1 
(0.7%) 
1 
(0.9%) 
 
VSD – ventricular septal defect 
TOF – Tetralogy of Fallot 
PS – pulmonary stenosis 
AVSD – atrioventricular septal defect 
 
Continuous variables are reported as medians and interquartile range.  
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TABLE 2: Change in Hospital Costs Pre- vs. Post-CPG  
 
CoA repair 
 
Group Pre-CPG Post-CPG Change 
Control 
$35,912  
($23,754-$54,291) 
$39,053  
($26,459-$57,643) 
8.4% (-25%, 41.7%) 
p = 0.6 
Active 
$44,535  
($32,105-$61,777) 
$39,196  
($27,552-$55,764) 
-12.8% (-41.1%, 15.6%) 
p = 0.4 
 
Difference-in-Difference 
-21.2% (-65.2%, 22.9%) 
p = 0.3 
TOF repair 
 
Group Pre-CPG Post-CPG Change 
Control 
$47,007  
($32,080-$68,882) 
$46,476  
($31,847-$67,823) 
-1.1% (-20.1%, 17.9%) 
p = 0.9 
Active 
$56,304  
($40,794-$77,711) 
$42,833  
($31,061-$59,067) 
-27.3% (-41.5%, -13.2%) 
p < 0.001 
 
Difference-in-Difference 
-26.2% (-49.9, -2.5) 
p = 0.03 
 
 
CoA = coarctation of the aorta, TOF = Tetralogy of Fallot 
 
Change denotes the percent change from pre- to post-CPG eras 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 15 
FIGURE LEGENDS 
 
Figure 1. Categories of Cost for TOF repair 
Specific categories of cost in the Tetralogy of Fallot (TOF) cohort are displayed, with percent 
change from pre- to post-clinical practice guideline (CPG) on the y-axis. Standard cost 
categories included: clinical, pharmacy, imaging, laboratory, supplies, and “other”.  The “other” 
category is primarily comprised of room and board costs. Notable for the present study, the 
clinical category contains costs related to mechanical ventilation and other respiratory care. 
There was a significant reduction in clinical, pharmacy, laboratory, and imaging costs, while 
supply and other costs remained unchanged.  
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